The Indian healthcare sector is a rapidly growing and evolving industry, driven by increasing demand, expanding infrastructure, and technological advancements.
The hospital sector in India was valued at Rs. 7,940.87 Bn in FY21 in terms of revenue & is expected to reach Rs. 18,348.78 Bn by FY 2027, growing at a CAGR of 18.24 percent. The Key drivers include rising population, increased incidence of non-communicable diseases, expanding medical tourism, and many more
Listed below are leading healthcare operators in India, with robust bed capacity and their average revenue per occupied bed (APROB)
Apollo Hospitals Enterprise
Apollo Hospitals Enterprise Limited is engaged in the business of providing hospital services and selling pharma and wellness products through a network of pharmacies, including the operation of multidisciplinary private hospitals, clinics, diagnostic centers, and pharmacies. Its segments include Healthcare Services, Retail Health and Diagnostics, Digital Health
With a market capitalization of Rs. 99,304 Crores, the shares of Apollo Hospitals Enterprise Limited were trading at Rs. 6,906.5 per equity share, up 0.04 percent from its previous day’s close price of Rs. 6,903.60
As of Q1FY25 Apollo Hospitals Enterprise Limited has a total bed capacity of 10,121 beds. It has an average revenue per occupied bed (ARPOB) of Rs. 59,073 and an average revenue per IP patient of Rs. 1,58,250.
Also read: Ashish Kacholia portfolio stocks with low debt to add to your watchlist
Its Revenue from operations grew by 15 percent YoY from Rs. 4,418 Crores in Q1FY24 to Rs. 5,086 Crores in Q1FY25, accompanied by profits of Rs. 173 Crores to Rs. 316 Crores.
Narayana Hrudayalaya
Narayana Hrudayalaya Limited is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.
With a market capitalization of Rs. 27,112 Crores, the shares of Narayana Hrudayalaya Limited opened with a flat movement at Rs. 1,326.70 per equity share, from its previous day’s close price of Rs. 1,326.70.
As of Q1FY25 Narayana Hrudayalaya Limited has a total bed capacity of 6,254 beds. It has an average revenue per occupied bed (ARPOB) of Rs. 41,369 and an average revenue per IP patient of Rs. 1,30,000.
Its Revenue from operations grew by 8.72 percent YoY from Rs. 1,233 Crores in Q1FY24 to Rs. 1,341 Crores in Q1FY25, accompanied by profits of Rs. 184 Crores to Rs. 202 Crores.
Aster DM Healthcare
Aster DM Healthcare Limited is a healthcare services provider with operations across hospitals, clinics, retail pharmacies, and many more.
With a market capitalization of Rs. 20,395 Crores, the shares of Aster DM Healthcare Limited were trading at Rs. 408.30 per equity share, down 0.07 percent from its previous day’s close price of Rs. 408.60.
As of Q1FY25 Aster DM Healthcare Limited has a total bed capacity of 4,869 beds, along with an average revenue per occupied bed (ARPOB) of Rs. 44,200+ and an average revenue per IP patient of Rs. 66,747+.
Its Revenue from operations grew by 19 percent YoY from Rs. 841 Crores in Q1FY24 to Rs. 1,002 Crores in Q1FY25, accompanied by profits of Rs. 20 Crores to Rs. 5,152 Crores. The sudden jump in net profits was generated as it sold a part of its business.
Fortis Healthcare
Fortis Healthcare Limited is a leading integrated healthcare service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics, and daycare specialty facilities.
With a market capitalization of Rs. 43,213 Crores, the shares of Fortis Healthcare Limited were trading at Rs. 572.40 per equity share, up 1 percent from its previous day’s close price of Rs. 566.60.
Also read: Stocks to Buy: 6 Stocks to buy now for an upside of 55%
As of Q1FY25 Aster DM Healthcare Limited has a total bed capacity of 4,600+ beds, along with an average revenue per occupied bed (ARPOB) of Rs. 65,924.
Its Revenue from operations grew by 12.16 percent YoY from Rs. 1,657 Crores in Q1FY24 to Rs. 1,859 Crores in Q1FY25, accompanied by profits of Rs. 124 Crores to Rs. 174 Crores.
Written by: Bharath K.S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
